Spotlighting the Cutting-Edge Research on Pre-Malignant Liver Disease – GENIAL-Horizon Europe
GENIAL-Horizon Europe shared a post on LinkedIn about a paper by Marko Šestan et al. published in Science:
“We’re proud to spotlight the cutting-edge research of our GENIAL project partners, recently published in Science.
This important contribution to the genomics of pre-malignant liver disease, strengthening the foundations of personalised medicine – one of the GENIAL project’s core missions.
By improving the interpretation of pre-cancer liver disease, this work brings us closer to equitable and effective cancer prevention and care across Europe.
Learn more about how the GENIAL project supports innovation in cancer diagnosis and treatment.”
Title: Neuronal-ILC2 interactions regulate pancreatic glucagon and glucose homeostasis
Authors: Marko Šestan, Bruno Raposo, Miguel Rendas, David Brea, Roksana Pirzgalska, Ana Rasteiro, Maria Aliseychik, Inês Godinho, Hélder Ribeiro, Tania Carvalho, Stephan Wueest, Daniel Konrad, and Henrique Veiga-Fernandes
You can read the Full Article in Science.
More posts featuring GENIAL-Horizon Europe.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023